Category News

Supplemental

Supplemental Screening Program Celebrates 20 Years, Urges Eligible Individuals to Join

National Supplemental Screening Program Celebrates 20 Years of Service; Eligible Individuals Encouraged to Participate The U.S. Department of Energy (DOE) National Supplemental Screening Program (NSSP), managed by ORAU, is celebrating 20 years of continued service and encourages those eligible to…

Read MoreSupplemental Screening Program Celebrates 20 Years, Urges Eligible Individuals to Join
Biotech Showcase

Biotech Showcase™ 2026 Highlighted Early-Stage Biotech Innovation During JPM Healthcare Week

Biotech Showcase™ 2026 Brought Early-Stage Biotech Innovation to the Forefront During JPM Healthcare Week As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year, the event continued to distinguish itself as a leading hub for early-stage biotechnology companies seeking meaningful visibility, strategic dialogue, and…

Read MoreBiotech Showcase™ 2026 Highlighted Early-Stage Biotech Innovation During JPM Healthcare Week
Magnus Medical

Magnus Medical Enrolls First Patient in DoD-Funded SAINT Postpartum Depression Study at UMass

Magnus Medical Announces First Patient Enrolled at University of Massachusetts in Pivotal DoD-Funded Multisite Study of SAINT for Postpartum Depression Magnus Medical, Inc., a pioneering therapeutic neuromodulation company advancing precision medicine in brain health, today announced enrollment of the first…

Read MoreMagnus Medical Enrolls First Patient in DoD-Funded SAINT Postpartum Depression Study at UMass
Health Canada

Health Canada Authorizes Mirum’s LIVMARLI® for PFIC-Related Cholestatic Pruritus Treatment

Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® for the Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC) Mirum Pharmaceuticals, Inc. a leading rare disease company, today announced that Health Canada has authorized LIVMARLI® (maralixibat) oral solution and…

Read MoreHealth Canada Authorizes Mirum’s LIVMARLI® for PFIC-Related Cholestatic Pruritus Treatment
Insulet

Insulet Introduces Omnipod® 5 and Omnipod Discover™ in the Middle East to Advance Diabetes Care

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care Insulet Corporation the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its transformative Omnipod 5 Automated Insulin Delivery (AID) System is now…

Read MoreInsulet Introduces Omnipod® 5 and Omnipod Discover™ in the Middle East to Advance Diabetes Care
Leyden

Leyden Labs Shows Feasibility of a Novel Antibody-Based Nasal Spray for Influenza Prevention

Leyden Labs Demonstrates Feasibility of Novel Antibody-Based Nasal Spray for Flu Prevention Leyden Laboratories B.V. (the “Company” or “Leyden Labs”) today announced landmark preclinical and clinical data in Science Translational Medicine supporting the development of their antibody-based nasal sprays to prevent influenza…

Read MoreLeyden Labs Shows Feasibility of a Novel Antibody-Based Nasal Spray for Influenza Prevention
Aya Locums

Aya Locums Physician Assistant Recognized as a 2025 Locum Tenens Provider of the Year by Locumpedia

Aya Locums’ Physician Assistant Named a “2025 Locum Tenens Providers of the Year” by Locumpedia Locumpedia named Alain Raymond, PA-C, a cardiothoracic surgical physician assistant with Aya Locums and a U.S. Navy veteran, as a “2025 Locum Tenens Providers of…

Read MoreAya Locums Physician Assistant Recognized as a 2025 Locum Tenens Provider of the Year by Locumpedia
Hims & Hers

Hims & Hers Introduces Multi-Cancer Early Detection Testing to Expand Access to Proactive Preventive Care

Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital health and wellness platform, launched access to the Hims & Hers Multi-Cancer Test by Galleri®,…

Read MoreHims & Hers Introduces Multi-Cancer Early Detection Testing to Expand Access to Proactive Preventive Care
Clarest Health

Clarest Health Launches “Clarest at Home” to Improve Medication Continuity from Facility to Home

Clarest Health Launches “Clarest at Home,” Closing the Gap in Medication Management from Facility to Front Door Clarest Health, a leader in personalized medication management, announced the launch of Clarest at Home, a comprehensive at-home medication care solution. This offering is…

Read MoreClarest Health Launches “Clarest at Home” to Improve Medication Continuity from Facility to Home